Blank A, Gallant J A, Burgess R R, Loeb L A
Biochemistry. 1986 Oct 7;25(20):5920-8. doi: 10.1021/bi00368a013.
A new Escherichia coli RNA polymerase mutant was isolated which exhibited reduced accuracy of chain elongation in vivo and in vitro. The novel isolation procedure consisted of simultaneous selection for rifampicin resistance and screening for increased leakiness of an early, strongly polar nonsense mutation of lacZ, one of a special class of mutations whose leakiness reflects mainly transcriptional rather than translational errors. The spontaneous mutant thus isolated displayed a 3-4-fold increase in the leakiness of two different lacZ mutations of this class. Transduction analysis indicated that a single mutation, mapping in or very near the rpoB gene for the beta subunit of RNA polymerase, conferred both rifampicin resistance and increased nonsense leakiness. In an in vitro fidelity assay, homogeneous RNA polymerases from the mutant and parent strains exhibited error rates of 1/0.90 X 10(5) and 1/2.0 X 10(5), respectively, for the poly[d(A-T)] X poly[d(A-T)]-directed misincorporation of noncomplementary GMP. These error rates were verified by product analyses which further revealed that GMP was misincorporated in place of AMP in the synthesis of poly[r(A-U)]. The error rate of wild-type K12 RNA polymerase from a different source was 1/2.0 X 10(5), while that of a hybrid RNA polymerase, containing mutant core enzyme and wild-type sigma subunit, was 1/0.64 X 10(5). These error rates confirmed the selection of a transcriptional accuracy mutant. The error frequencies observed are much lower than those reported in other in vitro assays. The safeguards used to avoid artifactually enhanced misincorporation, and to thereby quantitate lower error rates, are discussed.
分离出一种新的大肠杆菌RNA聚合酶突变体,该突变体在体内和体外均表现出链延伸准确性降低。新的分离程序包括同时选择对利福平的抗性,并筛选lacZ早期强极性无义突变的渗漏增加情况,lacZ突变是一类特殊的突变,其渗漏主要反映转录错误而非翻译错误。由此分离出的自发突变体在这类两个不同的lacZ突变体中渗漏增加了3至4倍。转导分析表明,一个单一突变位于RNA聚合酶β亚基的rpoB基因内或非常靠近该基因,赋予了对利福平的抗性和无义渗漏增加。在体外保真度测定中,来自突变体和亲本菌株的均一RNA聚合酶对于聚[d(A-T)]×聚[d(A-T)]指导的非互补GMP错掺入,错误率分别为1/0.90×10⁵和1/2.0×10⁵。这些错误率通过产物分析得到验证,产物分析进一步揭示在聚[r(A-U)]合成中,GMP错掺入取代了AMP。来自不同来源的野生型K12 RNA聚合酶的错误率为1/2.0×10⁵,而含有突变核心酶和野生型σ亚基的杂合RNA聚合酶的错误率为1/0.64×10⁵。这些错误率证实了选择了转录准确性突变体。观察到的错误频率远低于其他体外测定中报道的频率。讨论了用于避免人为增强错掺入从而定量较低错误率的保障措施。